DNAVSPS• 6 Months (Normalized)
DNA vs PS (Ginkgo Bioworks Holdings Inc. vs Pershing Square Inc.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+52.26%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
PS Performance $59.17
+144.5%
Pershing Square Inc.
Normalized Baseline0.00%
Alpha Spread Margin PS LEADS
-92.24 pts
PS outperforming by 92.24 percentage points
DNAPS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA PS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(122 dates)
| Date | DNA Price | DNA Gain (%) | PS Price | PS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +52.26% | $59.17 | +144.50% | -92.24% |
| Sep 25, 2026 | $10.66 | +55.17% | $56.16 | +132.07% | -76.90% |
| Sep 24, 2026 | $10.25 | +49.20% | $52.28 | +116.03% | -66.83% |
| Sep 23, 2026 | $8.58 | +24.89% | $49.99 | +106.57% | -81.68% |
| Sep 22, 2026 | $9.37 | +36.39% | $51.38 | +112.31% | -75.92% |
| Sep 21, 2026 | $7.98 | +16.16% | $48.23 | +99.30% | -83.14% |
| Sep 18, 2026 | $7.88 | +14.70% | $49.83 | +105.91% | -91.21% |
| Sep 17, 2026 | $7.84 | +14.12% | $43.83 | +81.12% | -67.00% |
| Sep 16, 2026 | $7.06 | +2.77% | $41.01 | +69.46% | -66.69% |
| Sep 15, 2026 | $6.99 | +1.75% | $39.00 | +61.16% | -59.41% |
| Sep 14, 2026 | $7.01 | +2.04% | $39.97 | +65.17% | -63.13% |
| Sep 11, 2026 | $6.75 | -1.75% | $37.67 | +55.66% | -57.41% |
| Sep 10, 2026 | $6.78 | -1.31% | $36.80 | +52.07% | -53.38% |
| Sep 09, 2026 | $6.79 | -1.16% | $36.48 | +50.74% | -51.90% |
| Sep 08, 2026 | $6.94 | +1.02% | $41.49 | +71.45% | -70.43% |
Page 1 of 9